自己免疫薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Autoimmune Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8100347)・商品コード:GIR8100347
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年9月24日
・ページ数:120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、自己免疫薬の世界市場について調べ、まとめました。種類別セグメントは、関節リウマチ(RA)、多発性硬化症(MS)、乾癬、炎症性腸疾患(IBD)、強直性脊椎炎(AS)、その他等、用途別セグメントは、病院、ホームケア設定、専門クリニック等に区分しました。自己免疫薬の世界市場概観、メーカー動向、メーカー別自己免疫薬シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・自己免疫薬の市場概観
・自己免疫薬のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・自己免疫薬のメーカー別販売動向、市場シェア、市場集中度、競争動向
・自己免疫薬の世界市場規模
・自己免疫薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・自己免疫薬のアメリカ市場規模推移
・自己免疫薬のカナダ市場規模推移
・自己免疫薬のメキシコ市場規模推移
・自己免疫薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・自己免疫薬のドイツ市場規模推移
・自己免疫薬のイギリス市場規模推移
・自己免疫薬のロシア市場規模推移
・自己免疫薬のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・自己免疫薬の日本市場規模推移
・自己免疫薬の中国市場規模推移
・自己免疫薬の韓国市場規模推移
・自己免疫薬のインド市場規模推移
・自己免疫薬の東南アジア市場規模推移
・自己免疫薬の南米市場分析(ブラジル、アルゼンチン等)
・自己免疫薬の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・自己免疫薬の種類別分析/市場規模推移(関節リウマチ(RA)、多発性硬化症(MS)、乾癬、炎症性腸疾患(IBD)、強直性脊椎炎(AS)、その他)
・自己免疫薬の用途別分析/市場規模推移(病院、ホームケア設定、専門クリニック)
・自己免疫薬の市場予測(地域別予測、種類別予測、用途別予測)
・自己免疫薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.

Scope of the Report:

This report focuses on the Autoimmune Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Autoimmune Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Eli Lilly

GSK

AbbVie

Johnson & Johnson

Biogen

Amgen

Pfizer

Roche

Baxter

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Rheumatoid Arthritis (RA)

Multiple Sclerosis (MS)

Psoriasis

Inflammatory Bowel Disease (IBD)

Ankylosing Spondylitis (AS)

Systemic Lupus Erythematosus (SLE)

Market Segment by Applications, can be divided into

Hospitals

Homecare Settings

Specialty Clinics

There are 15 Chapters to deeply display the global Autoimmune Drugs market.

Chapter 1, to describe Autoimmune Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Autoimmune Drugs, with sales, revenue, and price of Autoimmune Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Autoimmune Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Autoimmune Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Autoimmune Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview

1.1 Autoimmune Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Rheumatoid Arthritis (RA)

1.2.2 Multiple Sclerosis (MS)

1.2.3 Psoriasis

1.2.4 Inflammatory Bowel Disease (IBD)

1.2.5 Ankylosing Spondylitis (AS)

1.2.6 Systemic Lupus Erythematosus (SLE)

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Homecare Settings

1.3.3 Specialty Clinics

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Eli Lilly

2.1.1 Business Overview

2.1.2 Autoimmune Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Eli Lilly Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 GSK

2.2.1 Business Overview

2.2.2 Autoimmune Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GSK Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 AbbVie

2.3.1 Business Overview

2.3.2 Autoimmune Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AbbVie Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Johnson & Johnson

2.4.1 Business Overview

2.4.2 Autoimmune Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Johnson & Johnson Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Biogen

2.5.1 Business Overview

2.5.2 Autoimmune Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Biogen Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Amgen

2.6.1 Business Overview

2.6.2 Autoimmune Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Amgen Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Autoimmune Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Roche

2.8.1 Business Overview

2.8.2 Autoimmune Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Roche Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Baxter

2.9.1 Business Overview

2.9.2 Autoimmune Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Baxter Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Autoimmune Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Autoimmune Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Autoimmune Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Autoimmune Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Autoimmune Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Autoimmune Drugs Market Analysis by Regions

4.1 Global Autoimmune Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Autoimmune Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Autoimmune Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Autoimmune Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Autoimmune Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Autoimmune Drugs Sales and Growth Rate (2013-2018)

4.5 South America Autoimmune Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Autoimmune Drugs Sales and Growth Rate (2013-2018)

5 North America Autoimmune Drugs by Countries

5.1 North America Autoimmune Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Autoimmune Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Autoimmune Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Autoimmune Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Autoimmune Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Autoimmune Drugs Sales and Growth Rate (2013-2018)

6 Europe Autoimmune Drugs by Countries

6.1 Europe Autoimmune Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Autoimmune Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Autoimmune Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Autoimmune Drugs Sales and Growth Rate (2013-2018)

6.3 UK Autoimmune Drugs Sales and Growth Rate (2013-2018)

6.4 France Autoimmune Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Autoimmune Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Autoimmune Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Autoimmune Drugs by Countries

7.1 Asia-Pacific Autoimmune Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Autoimmune Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Autoimmune Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Autoimmune Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Autoimmune Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Autoimmune Drugs Sales and Growth Rate (2013-2018)

7.5 India Autoimmune Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Autoimmune Drugs Sales and Growth Rate (2013-2018)

8 South America Autoimmune Drugs by Countries

8.1 South America Autoimmune Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Autoimmune Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Autoimmune Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Autoimmune Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Autoimmune Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Autoimmune Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Autoimmune Drugs by Countries

9.1 Middle East and Africa Autoimmune Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Autoimmune Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Autoimmune Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Autoimmune Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Autoimmune Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Autoimmune Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Autoimmune Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Autoimmune Drugs Sales and Growth Rate (2013-2018)

10 Global Autoimmune Drugs Market Segment by Type

10.1 Global Autoimmune Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Autoimmune Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Autoimmune Drugs Revenue and Market Share by Type (2013-2018)

10.2 Rheumatoid Arthritis (RA) Sales Growth and Price

10.2.1 Global Rheumatoid Arthritis (RA) Sales Growth (2013-2018)

10.2.2 Global Rheumatoid Arthritis (RA) Price (2013-2018)

10.3 Multiple Sclerosis (MS) Sales Growth and Price

10.3.1 Global Multiple Sclerosis (MS) Sales Growth (2013-2018)

10.3.2 Global Multiple Sclerosis (MS) Price (2013-2018)

10.4 Psoriasis Sales Growth and Price

10.4.1 Global Psoriasis Sales Growth (2013-2018)

10.4.2 Global Psoriasis Price (2013-2018)

10.5 Inflammatory Bowel Disease (IBD) Sales Growth and Price

10.5.1 Global Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)

10.5.2 Global Inflammatory Bowel Disease (IBD) Price (2013-2018)

10.6 Ankylosing Spondylitis (AS) Sales Growth and Price

10.6.1 Global Ankylosing Spondylitis (AS) Sales Growth (2013-2018)

10.6.2 Global Ankylosing Spondylitis (AS) Price (2013-2018)

10.7 Systemic Lupus Erythematosus (SLE) Sales Growth and Price

10.7.1 Global Systemic Lupus Erythematosus (SLE) Sales Growth (2013-2018)

10.7.2 Global Systemic Lupus Erythematosus (SLE) Price (2013-2018)

11 Global Autoimmune Drugs Market Segment by Application

11.1 Global Autoimmune Drugs Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Homecare Settings Sales Growth (2013-2018)

11.4 Specialty Clinics Sales Growth (2013-2018)

12 Autoimmune Drugs Market Forecast (2018-2023)

12.1 Global Autoimmune Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Autoimmune Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Autoimmune Drugs Market Forecast (2018-2023)

12.2.2 Europe Autoimmune Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Autoimmune Drugs Market Forecast (2018-2023)

12.2.4 South America Autoimmune Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Autoimmune Drugs Market Forecast (2018-2023)

12.3 Autoimmune Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Autoimmune Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Autoimmune Drugs Market Share Forecast by Type (2018-2023)

12.4 Autoimmune Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Autoimmune Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Autoimmune Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Autoimmune Drugs Picture

Table Product Specifications of Autoimmune Drugs

Figure Global Sales Market Share of Autoimmune Drugs by Types in 2017

Table Autoimmune Drugs Types for Major Manufacturers

Figure Rheumatoid Arthritis (RA) Picture

Figure Multiple Sclerosis (MS) Picture

Figure Psoriasis Picture

Figure Inflammatory Bowel Disease (IBD) Picture

Figure Ankylosing Spondylitis (AS) Picture

Figure Systemic Lupus Erythematosus (SLE) Picture

Figure Autoimmune Drugs Sales Market Share by Applications in 2017

Figure Hospitals Picture

Figure Homecare Settings Picture

Figure Specialty Clinics Picture

Figure United States Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Autoimmune Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Autoimmune Drugs Type and Applications

Table Eli Lilly Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GSK Basic Information, Manufacturing Base and Competitors

Table GSK Autoimmune Drugs Type and Applications

Table GSK Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Autoimmune Drugs Type and Applications

Table AbbVie Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Autoimmune Drugs Type and Applications

Table Johnson & Johnson Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biogen Basic Information, Manufacturing Base and Competitors

Table Biogen Autoimmune Drugs Type and Applications

Table Biogen Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Autoimmune Drugs Type and Applications

Table Amgen Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Autoimmune Drugs Type and Applications

Table Pfizer Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Autoimmune Drugs Type and Applications

Table Roche Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Baxter Basic Information, Manufacturing Base and Competitors

Table Baxter Autoimmune Drugs Type and Applications

Table Baxter Autoimmune Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Autoimmune Drugs Sales by Manufacturer (2016-2017)

Figure Global Autoimmune Drugs Sales Market Share by Manufacturer in 2016

Figure Global Autoimmune Drugs Sales Market Share by Manufacturer in 2017

Table Global Autoimmune Drugs Revenue by Manufacturer (2016-2017)

Figure Global Autoimmune Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Autoimmune Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Autoimmune Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Autoimmune Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Global Autoimmune Drugs Revenue and Growth Rate (2013-2018)

Table Global Autoimmune Drugs Sales by Regions (2013-2018)

Table Global Autoimmune Drugs Sales Market Share by Regions (2013-2018)

Table Global Autoimmune Drugs Revenue by Regions (2013-2018)

Figure Global Autoimmune Drugs Revenue Market Share by Regions in 2013

Figure Global Autoimmune Drugs Revenue Market Share by Regions in 2017

Figure North America Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Europe Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure South America Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure North America Autoimmune Drugs Revenue and Growth Rate (2013-2018)

Table North America Autoimmune Drugs Sales by Countries (2013-2018)

Table North America Autoimmune Drugs Sales Market Share by Countries (2013-2018)

Figure North America Autoimmune Drugs Sales Market Share by Countries in 2013

Figure North America Autoimmune Drugs Sales Market Share by Countries in 2017

Table North America Autoimmune Drugs Revenue by Countries (2013-2018)

Table North America Autoimmune Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Autoimmune Drugs Revenue Market Share by Countries in 2013

Figure North America Autoimmune Drugs Revenue Market Share by Countries in 2017

Figure United States Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Canada Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Europe Autoimmune Drugs Revenue and Growth Rate (2013-2018)

Table Europe Autoimmune Drugs Sales by Countries (2013-2018)

Table Europe Autoimmune Drugs Sales Market Share by Countries (2013-2018)

Table Europe Autoimmune Drugs Revenue by Countries (2013-2018)

Figure Europe Autoimmune Drugs Revenue Market Share by Countries in 2016

Figure Europe Autoimmune Drugs Revenue Market Share by Countries in 2017

Figure Germany Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure UK Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure France Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Russia Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Italy Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Autoimmune Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Autoimmune Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Autoimmune Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Autoimmune Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Autoimmune Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Autoimmune Drugs Revenue Market Share by Countries 2017

Figure China Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Japan Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Korea Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure India Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure South America Autoimmune Drugs Revenue and Growth Rate (2013-2018)

Table South America Autoimmune Drugs Sales by Countries (2013-2018)

Table South America Autoimmune Drugs Sales Market Share by Countries (2013-2018)

Figure South America Autoimmune Drugs Sales Market Share by Countries in 2017

Table South America Autoimmune Drugs Revenue by Countries (2013-2018)

Table South America Autoimmune Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Autoimmune Drugs Revenue Market Share by Countries in 2017

Figure Brazil Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Autoimmune Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Autoimmune Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Autoimmune Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Autoimmune Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Autoimmune Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Autoimmune Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Autoimmune Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Autoimmune Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure UAE Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Autoimmune Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Autoimmune Drugs Sales and Growth Rate (2013-2018)

Table Global Autoimmune Drugs Sales by Type (2013-2018)

Table Global Autoimmune Drugs Sales Share by Type (2013-2018)

Table Global Autoimmune Drugs Revenue by Type (2013-2018)

Table Global Autoimmune Drugs Revenue Share by Type (2013-2018)

Figure Global Rheumatoid Arthritis (RA) Sales Growth (2013-2018)

Figure Global Rheumatoid Arthritis (RA) Price (2013-2018)

Figure Global Multiple Sclerosis (MS) Sales Growth (2013-2018)

Figure Global Multiple Sclerosis (MS) Price (2013-2018)

Figure Global Psoriasis Sales Growth (2013-2018)

Figure Global Psoriasis Price (2013-2018)

Figure Global Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)

Figure Global Inflammatory Bowel Disease (IBD) Price (2013-2018)

Figure Global Ankylosing Spondylitis (AS) Sales Growth (2013-2018)

Figure Global Ankylosing Spondylitis (AS) Price (2013-2018)

Figure Global Systemic Lupus Erythematosus (SLE) Sales Growth (2013-2018)

Figure Global Systemic Lupus Erythematosus (SLE) Price (2013-2018)

Table Global Autoimmune Drugs Sales by Application (2013-2018)

Table Global Autoimmune Drugs Sales Share by Application (2013-2018)

Figure Global Homecare Settings Sales Growth (2013-2018)

Figure Global Specialty Clinics Sales Growth (2013-2018)

Figure Global Autoimmune Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Autoimmune Drugs Sales Forecast by Regions (2018-2023)

Table Global Autoimmune Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Autoimmune Drugs Market Forecast (2018-2023)

Figure Europe Sales Autoimmune Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Autoimmune Drugs Market Forecast (2018-2023)

Figure South America Sales Autoimmune Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Autoimmune Drugs Market Forecast (2018-2023)

Table Global Autoimmune Drugs Sales Forecast by Type (2018-2023)

Table Global Autoimmune Drugs Market Share Forecast by Type (2018-2023)

Table Global Autoimmune Drugs Sales Forecast by Application (2018-2023)

Table Global Autoimmune Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List



【レポートのキーワード】

自己免疫薬、関節リウマチ(RA)、多発性硬化症(MS)、乾癬、炎症性腸疾患(IBD)、強直性脊椎炎(AS)、その他、病院、ホームケア設定、専門クリニック

★調査レポート[自己免疫薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8100347)販売に関する免責事項を必ずご確認ください。
★調査レポート[自己免疫薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆